SCHEMBL387892

SCHEMBL387892

C[C@@H](O)c1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL153285 1.00
SCHEMBL3062521 1.00
Ammonia Solution, Strong SCHEMBL4910284 0.97 CYP3A4 (0.46)
SCHEMBL28114287 0.85 CYP17A1 (0.53)
SCHEMBL27083996 0.79 CYP3A4 (0.44)
SCHEMBL18810809 0.79 CYP3A4 (0.44)
SCHEMBL9331652 0.78 NOS3 (0.54)
SCHEMBL40655 0.78 NOS3 (0.54)
SCHEMBL9331061 0.78 NOS3 (0.54)
SCHEMBL9331190 0.78 NOS3 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119776301-A Alcohol dehydrogenase, recombinant genetically engineered bacterium and application thereof in asymmetric reduction of potential chiral carbonyl compounds 杭州文德阶生物科技有限公司 2025-04-08 CN claimed
EP-0304706-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUNDS HAVING PYRIDINE SKELETONS CHISSO CORPORATION (JP) 1992-11-19 EP claimed
US-4971909-A TRANSESTERIFICATION IN THE PRESENCE OF HYDROLASES CHISSO CORPORATION (JP) 1990-11-20 US claimed
EP-0304706-A2 Process for producing optically active compounds having pyridine skeletons CHISSO CORPORATION (JP) 1989-03-01 EP claimed
US-12577200-B2 High-throughput method to rapidly add chemical moieties to a small molecule library MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2026-03-17 US disclosed
US-20250214984-A1 COMPOUND HAVING KDM5 INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2025-07-03 US disclosed
EP-4146645-B1 3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF ONO PHARMACEUTICAL CO (JP) 2025-06-25 EP disclosed
US-20250129067-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2025-04-24 US disclosed
US-12269817-B2 Compound having KDM5 inhibitory activity and pharmaceutical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2025-04-08 US disclosed
CN-119776301-A Alcohol dehydrogenase, recombinant genetically engineered bacterium and application thereof in asymmetric reduction of potential chiral carbonyl compounds 杭州文德阶生物科技有限公司 2025-04-08 CN disclosed
EP-4471027-A1 3-AZABICYCLO(3.1.0)HEXANE DERIVATIVES HAVING KDM5 INHIBITORY ACTIVITY AND USE THEREOF ONO Pharmaceutical Co., Ltd. (JP) 2024-12-04 EP disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
EP-0640072-A1 SUBSTITUTED PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL USE BTG INTERNATIONAL LIMITED (GB) 1995-03-01 EP disclosed
EP-0336619-B1 Optically active pyridylethanol derivatives CHISSO CORP (JP) 1995-02-22 EP disclosed
WO-1993023375-A1 SUBSTITUTED PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL USE BRITISH TECHNOLOGY GROUP LIMITED (GB) 1993-11-25 WO disclosed
EP-0304706-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUNDS HAVING PYRIDINE SKELETONS CHISSO CORPORATION (JP) 1992-11-19 EP disclosed
US-4971909-A TRANSESTERIFICATION IN THE PRESENCE OF HYDROLASES CHISSO CORPORATION (JP) 1990-11-20 US disclosed
US-4965018-A LIQUID CRYSTAL; HIGH TWISTABILITY, TEMPERTURE CHARACTERISTICS CHISSO CORPORATION (JP) 1990-10-23 US disclosed
EP-0336619-A2 Optically active pyridylethanol derivatives Chisso Corporation (JP) 1989-10-11 EP disclosed
EP-0304706-A2 Process for producing optically active compounds having pyridine skeletons CHISSO CORPORATION (JP) 1989-03-01 EP disclosed